Photochemistry and Photobiology · 2002 · 50 citations · 28 references
Natural SciencesBiophysicsPharmacologyBiomedical OpticsBiophotonicsMolecular ImagingFluorescence SpectroscopyPhotochemical KineticsPhotochemistryPhotodynamic TherapyPhotophysics Of Fluorescent ProbesBleachingCancer Photodynamic TherapyCell Viability AssaysDosimetry ModelingLight DosimetryOxygenationPhotosensitizersPhotosensitizing Compounds
An implicit dosimetric model has been proposed in which biological damage caused by photodynamic therapy (PDT) is monitored through the decrease in sensitizer fluorescence during treatment. To investigate this, in vitro experiments were performed in which DP16 cells were incubated in meta-tetra(hydroxyphenyl)chlorin (mTHPC) and then irradiated with 514 nm light. Photosensitizer concentration, fluence rate and oxygenation were independently controlled and monitored during the treatment. Fluorescence of mTHPC was continuously monitored via a charge-coupled device-coupled spectrometer during treatment and, at selected fluence levels, cell viability was determined using a trypan blue exclusion assay. The relationship of cell viability to normalized fluorescence was obtained for the different treatment conditions. The relationship was independent of cell medium oxygenation, treatment fluence rate and sensitizer incubation concentration except at a high mTHPC concentration (4 microg/mL). This relationship suggests that fluorescence bleaching may be used to predict mTHPC PDT damage in vitro.
28
Dominic J. Robinson, Henriëtte S. de Bruijn, Nynke van der Veen et al. · Photochemistry and Photobiology · 1998 · 262 citations · Full text